To determine the function(s) of G9a directly associated with AD pathogenesis, we used our chromatin activity-based chemoproteomics (ChaC)-mass spectrometry (MS)12 approach with UNC0965, a biotinylated version of a G9a inhibitor13, to dissect G9a pathways in AD. The gene discussed is EHMT2; the disease is Alzheimer disease.